Filing Details
LENZ Therapeutics, Inc. (NASDAQ:LENZ) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event.
8k filedNASDAQ:LENZ
LENZ Therapeutics, Inc. (LENZ) Reports Material Event to SEC
Filing Details LENZ Therapeutics, Inc. (NASDAQ:LENZ) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market Context…
Market Context
LENZ Therapeutics, Inc.'s stock currently trades at $5.89 with a market capitalization of $684.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for LENZ Therapeutics, Inc.'s stock.
All SEC filings for LENZ Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View LENZ Stock Page
Frequently Asked Questions
Where can I read LENZ's SEC filings?
Browse all filings on our LENZ SEC filings page.
What types of SEC filings does LENZ Therapeutics, Inc. file?
Public companies like LENZ Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.